A. Poyraz Et Al. , "P21 and bax expression in cutaneous malignant melanomas: Correlation with histologic prognostic parameters," JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.23, no.4, pp.625-631, 2004
Poyraz, A. Et Al. 2004. P21 and bax expression in cutaneous malignant melanomas: Correlation with histologic prognostic parameters. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.23, no.4 , 625-631.
Poyraz, A., Akyurek, N., Gonul, I., & ERDEM, O. A., (2004). P21 and bax expression in cutaneous malignant melanomas: Correlation with histologic prognostic parameters. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.23, no.4, 625-631.
Poyraz, A Et Al. "P21 and bax expression in cutaneous malignant melanomas: Correlation with histologic prognostic parameters," JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.23, no.4, 625-631, 2004
Poyraz, A Et Al. "P21 and bax expression in cutaneous malignant melanomas: Correlation with histologic prognostic parameters." JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.23, no.4, pp.625-631, 2004
Poyraz, A. Et Al. (2004) . "P21 and bax expression in cutaneous malignant melanomas: Correlation with histologic prognostic parameters." JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.23, no.4, pp.625-631.
@article{article, author={A Poyraz Et Al. }, title={P21 and bax expression in cutaneous malignant melanomas: Correlation with histologic prognostic parameters}, journal={JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH}, year=2004, pages={625-631} }